Cisatracurium Kabi Drug Interactions

Antibiotics (e.g. aminoglycosides, clindamycin, lincomycin): Certain antibiotics may enhance the neuromuscular blocking action of cisatracurium.
Carbamazepine: The effects of long-term carbamazepine therapy on the action of cisatracurium are unknown, slightly shorter durations of neuromuscular block may be anticipated an infusion rate requirements may be higher.
Cyclosporin: Cyclosporin may enhance the neuromuscular blocking action of cisatracurium.
General anesthetics (e.g. enflurane, isoflurane): General anesthetics may potentiate the actions of cisatracurium.
Hydantoins (e.g. phenytoin): Resistance to the neuromuscular blocking agents has been demonstrated in patients administered phenytoin long term.
Ketamine: Ketamine may enhance the neuromuscular blocking action of cisatracurium.
Lithium: Lithium may enhance the neuromuscular blocking action of cisatracurium.
Local anesthetics (e.g. lidocaine): Local anesthetics may enhance the neuromuscular blocking action of cisatracurium.
Magnesium salts: Magnesium salts may enhance the neuromuscular blocking action of cisatracurium.
Quinidine: Quinidine may enhance the neuromuscular blocking action of cisatracurium.
Procainamide: Procainamide may enhance the neuromuscular blocking action of cisatracurium.
Theophyllines: Neuromuscular blocking effects of cisatracurium may be decreased by theophyllines. Cardiac arrhythmia may be occurred. Consider avoiding coadministration.
Thiazide diuretics (e.g. chlorothiazide): The neuromuscular-blocking effects of cisatracurium may be increased because of thiazide diuretic-induced hypokalemia.
Verapamil: Verapamil may enhance the neuromuscular blocking action of cisatracurium.